Bombay Oxygen Investments Limited (BOMOXY-B1.BO)
INR 31152.0
(-1.73%)
INR 31152.0
(-1.73%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.65 Million | -54.05 Million | -26.8 Million | -16.39 Million | -22.57 Million | -27.31 Million |
| Net Income | 576 Million | 50.19 Million | 315.58 Million | 654.49 Million | -200.38 Million | 61.05 Million |
| Depreciation & Amortization | 1.94 Million | 1.88 Million | 1.9 Million | 1.94 Million | 2.03 Million | 2.85 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -111 Thousand | -35.62 Million | -4.66 Million | -52.81 Million | 9.42 Million | -2.24 Million |
| Other non-cash items | -571.2 Million | -70.51 Million | -339.63 Million | -620.01 Million | 166.35 Million | -88.98 Million |
| Investing Cash Flow | 64 Thousand | 54.03 Million | 31.83 Million | 13.67 Million | 27.07 Million | 28.09 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | 39.94 Million | 150 Thousand | 522 Thousand | 9.33 Million | 3.49 Million |
| Investment purchases | - | - | - | - | - | -23.24 Million |
| Sales/Maturities of investments | - | - | 20.21 Million | 10 Thousand | 46 Thousand | - |
| Other Investing Activities | 64 Thousand | 14.08 Million | 11.47 Million | 13.13 Million | 17.69 Million | 47.84 Million |
| Financing Cash Flow | -2.25 Million | -3 Million | -3 Million | -1.5 Million | -1.8 Million | -1.8 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -2.25 Million | -3 Million | -3 Million | -1.5 Million | -1.5 Million | -1.5 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -308 Thousand | -305 Thousand |
| Accounts receivables | - | - | - | 19 Thousand | 1.07 Million | 823 Thousand |
| Accounts payables | -96 Thousand | -95 Thousand | -1.66 Million | -492 Thousand | -480 Thousand | -1.78 Million |
| Inventory | - | - | - | -53.43 Million | 133 Thousand | -62 Thousand |
| Other working capital | -15 Thousand | -35.52 Million | -2.99 Million | 1.09 Million | 8.69 Million | -1.21 Million |
| Cash at beginning of period | 1.42 Million | 3.49 Million | 1.46 Million | 5.68 Million | 3.78 Million | 4.81 Million |
| Cash at end of period | 1.66 Million | 465 Thousand | 3.49 Million | 1.46 Million | 6.47 Million | 3.78 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | -1000.00 | - | - | - | - |
| Net cash flow / Change in cash | 233 Thousand | -3.02 Million | 2.02 Million | -4.22 Million | 2.69 Million | -1.03 Million |
| Free Cash Flow | 2.65 Million | -54.05 Million | -26.8 Million | -16.39 Million | -22.57 Million | -27.31 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 576 Million | 174.71 Million | 118.64 Million | 195.7 Million | 50.19 Million | -21.64 Million |
| Depreciation & Amortization | 1.94 Million | 486 Thousand | 485 Thousand | 485 Thousand | 1.88 Million | 548 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -111 Thousand | - | - | - | -35.62 Million | - |
| Other non-cash items | -571.2 Million | -486 Thousand | -485 Thousand | -485 Thousand | -70.51 Million | -548 Thousand |
| Investing Cash Flow | 64 Thousand | - | - | - | 54.03 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | 39.94 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 64 Thousand | - | - | - | 14.08 Million | - |
| Financing Cash Flow | -2.25 Million | - | - | - | -3 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -2.25 Million | - | - | - | -3 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -96 Thousand | - | - | - | -95 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -15 Thousand | - | - | - | -35.52 Million | - |
| Cash at beginning of period | 1.42 Million | 27.94 Million | -90.7 Million | 1.42 Million | 3.49 Million | 23.07 Million |
| Cash at end of period | 1.66 Million | 174.71 Million | 27.94 Million | 195.7 Million | 465 Thousand | 1.42 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | -1000.00 | - |
| Net cash flow / Change in cash | 233 Thousand | 146.77 Million | 118.64 Million | 194.27 Million | -3.02 Million | -21.64 Million |
| Free Cash Flow | 2.65 Million | 174.71 Million | 118.64 Million | 195.7 Million | -54.05 Million | -21.64 Million |
4381
MZA
BCBNF
BDRAF
ORIBEVER
6138